Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients
Authors:
- 1 January 2008
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 34 (1) , 82-88
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The Microanatomic Location of Metastatic Melanoma in Sentinel Lymph Nodes Predicts Nonsentinel Lymph Node InvolvementJournal of Clinical Oncology, 2004
- Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel nodeLaboratory Investigation, 2004
- Clinical Outcome of Stage I/II Melanoma Patients After Selective Sentinel Lymph Node Dissection: Long-Term Follow-Up ResultsJournal of Clinical Oncology, 2003
- Prediction of Nonsentinel Lymph Node Status in MelanomaAnnals of Surgical Oncology, 2003
- Frequency of nonsentinel lymph node metastasis in melanomaAnnals of Surgical Oncology, 2002
- Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging SystemJournal of Clinical Oncology, 2001
- A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanomaCancer, 2001
- Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanomaCancer, 2000
- Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma PatientsJournal of Clinical Oncology, 1999
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996